CN Patent

CN104784174A — 右美托咪定的药物新用途

Assigned to Peking University First Hospital · Expires 2015-07-22 · 11y expired

What this patent protects

本发明公开了一种右美托咪定新用途。本发明提供的右美托咪定或其药学上可接受的盐的新用途是其在制备下述产品中的应用:1)预防和/或治疗术后睡眠障碍的产品;2)预防或降低术后并发症的产品;3)改善术后预后的产品。药效试验表明,对于老年非心脏手术病人,小剂量右美托咪定静脉输注可以明显改善术后睡眠结构和主观睡眠质量;而且同时也可改善病人的预后,包括降低疼痛程度、减少术后谵妄和非谵妄并发症发生和缩短ICU停留时间。

USPTO Abstract

本发明公开了一种右美托咪定新用途。本发明提供的右美托咪定或其药学上可接受的盐的新用途是其在制备下述产品中的应用:1)预防和/或治疗术后睡眠障碍的产品;2)预防或降低术后并发症的产品;3)改善术后预后的产品。药效试验表明,对于老年非心脏手术病人,小剂量右美托咪定静脉输注可以明显改善术后睡眠结构和主观睡眠质量;而且同时也可改善病人的预后,包括降低疼痛程度、减少术后谵妄和非谵妄并发症发生和缩短ICU停留时间。

Drugs covered by this patent

Patent Metadata

Patent number
CN104784174A
Jurisdiction
CN
Classification
Expires
2015-07-22
Drug substance claim
No
Drug product claim
No
Assignee
Peking University First Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.